The possibilities of using oseltamivir in children in modern conditions: clinical practice

According to statistics, the acute respiratory diseases incidence in paediatric population is much higher than adult population, due immature immune system, beginning of active contacts organized groups, and often lack habits skills sanitary hygiene. Given anatomical physiological features, children have more pronounced symptoms, which causes not only a faster visit doctor, but also reports polypharmacy practice. The article presents detailed differential diagnosis viral infections, including influenza COVID-19, according leading clinical symptoms syndromes. possibilities features action main drugs used for treatment ARVI children’s practice – oseltamivir, umifenovir interferon alpha-2b are described. Using examples, tactics choosing regimen routine work pediatrician, taking into account impact ongoing COVID-19 pandemic modern conditions, considered. advantages using oseltamivir shown. first case report: 6-year-old child diagnosed with an upper infection: nasopharyngitis, epidemiological moderate severe influenza. Severe fever leukopenia syndrome on third day illness pointed possibility disease progression development complications, justified selection as most effective well-established anti-influenza drug. second 3-yearold High-grade fever, neutrophilia absence elevated levels leukocytes, high level C-reactive protein signs bacterial infection, determined choice oseltamivir. practical administration demonstrates reduction risk developing influenza, reversing intoxication other manifestations well prevention if timely manner.